IL310225A - Recombinant mycobacterium as an immunotherapeutic agent for the second-line therapy of bladder carcinoma - Google Patents
Recombinant mycobacterium as an immunotherapeutic agent for the second-line therapy of bladder carcinomaInfo
- Publication number
- IL310225A IL310225A IL310225A IL31022524A IL310225A IL 310225 A IL310225 A IL 310225A IL 310225 A IL310225 A IL 310225A IL 31022524 A IL31022524 A IL 31022524A IL 310225 A IL310225 A IL 310225A
- Authority
- IL
- Israel
- Prior art keywords
- immunotherapeutic agent
- bladder carcinoma
- line therapy
- recombinant mycobacterium
- mycobacterium
- Prior art date
Links
- 206010005003 Bladder cancer Diseases 0.000 title 1
- 241000186359 Mycobacterium Species 0.000 title 1
- 201000001531 bladder carcinoma Diseases 0.000 title 1
- 239000002955 immunomodulating agent Substances 0.000 title 1
- 238000009094 second-line therapy Methods 0.000 title 1
- 208000010570 urinary bladder carcinoma Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
- A61K2039/585—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/80—Vaccine for a specifically defined cancer
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163224575P | 2021-07-22 | 2021-07-22 | |
| EP21187253.6A EP4122491A1 (en) | 2021-07-22 | 2021-07-22 | Recombinant microbacterium as an immunotherapeutic agent for the second-line therapy of bladder carcinoma |
| US17/667,784 US20220160858A1 (en) | 2015-05-04 | 2022-02-09 | Recombinant Mycobacterium as an Immunotherapeutic Agent for the Treatment of Cancer |
| PCT/EP2022/070373 WO2023001895A1 (en) | 2021-07-22 | 2022-07-20 | Recombinant mycobacterium as an immunotherapeutic agent for the second-line therapy of bladder carcinoma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL310225A true IL310225A (en) | 2024-03-01 |
Family
ID=82846547
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL310225A IL310225A (en) | 2021-07-22 | 2022-07-20 | Recombinant mycobacterium as an immunotherapeutic agent for the second-line therapy of bladder carcinoma |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP4373519A1 (en) |
| JP (1) | JP2024530404A (en) |
| KR (1) | KR20240082332A (en) |
| AU (1) | AU2022313491A1 (en) |
| CA (1) | CA3224671A1 (en) |
| IL (1) | IL310225A (en) |
| MX (1) | MX2024000980A (en) |
| WO (1) | WO2023001895A1 (en) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5733151A (en) | 1996-08-23 | 1998-03-31 | Edsall; David | Electrical clamping connection device |
| AUPO761697A0 (en) | 1997-06-30 | 1997-07-24 | Cardiac Crc Nominees Pty Limited | Process for the purification of polyethers |
| CN1798762B (en) | 2003-04-23 | 2010-04-28 | 马普科技促进协会 | Tuberculosis vaccine with improved efficacy |
| SI2654783T1 (en) | 2010-12-21 | 2017-02-28 | Max-Planck-Gesellschaft zur Fourderung der Wissenschaften e.V. | Recombinant mycobacterium as a vaccine |
| EP3090757A1 (en) | 2015-05-04 | 2016-11-09 | Vakzine Projekt Management GmbH | Recombinant mycobacterium as an immunotherapeutic agent for the treatment of cancer |
-
2022
- 2022-07-20 JP JP2024501689A patent/JP2024530404A/en active Pending
- 2022-07-20 EP EP22751731.5A patent/EP4373519A1/en active Pending
- 2022-07-20 WO PCT/EP2022/070373 patent/WO2023001895A1/en active Application Filing
- 2022-07-20 AU AU2022313491A patent/AU2022313491A1/en active Pending
- 2022-07-20 KR KR1020247005936A patent/KR20240082332A/en unknown
- 2022-07-20 MX MX2024000980A patent/MX2024000980A/en unknown
- 2022-07-20 CA CA3224671A patent/CA3224671A1/en active Pending
- 2022-07-20 IL IL310225A patent/IL310225A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20240082332A (en) | 2024-06-10 |
| JP2024530404A (en) | 2024-08-21 |
| CA3224671A1 (en) | 2023-01-26 |
| AU2022313491A1 (en) | 2024-01-18 |
| EP4373519A1 (en) | 2024-05-29 |
| WO2023001895A1 (en) | 2023-01-26 |
| MX2024000980A (en) | 2024-06-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL286457A (en) | Safety integrated personal mobility vehicle | |
| IL281586A (en) | Compositions and methods for manufacturing gene therapy vectors | |
| EP3930747A4 (en) | Immunotherapeutic combination for treating cancer | |
| IL276399A (en) | Combination therapy for the treatment of gastrointestinal stromal tumors | |
| EP3755711A4 (en) | Immunotherapeutic composition for the treatment of cancer | |
| EP4081248A4 (en) | Therapy for the treatment of cancer | |
| SG11202109274TA (en) | Immunotherapy for the treatment of cancer | |
| SG11202101819QA (en) | Gene therapy for the treatment of galactosemia | |
| IL281845A (en) | Combination therapy for the treatment of cancer | |
| PL3620479T3 (en) | Tin-free catalysis of silane-functional polyurethane crosslinking agents | |
| EP4010081A4 (en) | Combination therapy for treatment of cancer | |
| IL310225A (en) | Recombinant mycobacterium as an immunotherapeutic agent for the second-line therapy of bladder carcinoma | |
| EP4031130A4 (en) | Compositions for the treatment of solid tumors | |
| GB201919428D0 (en) | Immunotherapeutic treatment of cancer | |
| SG11202105736QA (en) | Combination therapy for the treatment of cancer | |
| SG11202107618WA (en) | Mobile device for treatment of itching, having an interface | |
| HK1247574A1 (en) | Recombinant mycobacterium as an immunotherapeutic agent for the treatment of cancer | |
| IL281997A (en) | Combination therapy for the treatment of uveal melanoma | |
| GB201800736D0 (en) | Combination therapy for treatment of leukemia | |
| SG11202011434SA (en) | Methods for the treatment of bladder cancer | |
| IL286353A (en) | Combinations of iadademstat for cancer therapy | |
| EP4099996A4 (en) | Foam compositions for the treatment of cancer | |
| EP4027984A4 (en) | Combination therapy for the treatment of migraines | |
| EP4228872C0 (en) | Foamed biogranulate grains | |
| GB202306292D0 (en) | Methods and compositions for cellular therapy |